At just two-and-a-half years old, the University of Wisconsin–Madison Human Stem Cell Gene Editing Service is already contemplating expansion. The increased demand has tracked the growth of research projects on campus using a new gene editing tool called CRISPR-Cas9.
The service derives and genetically engineers pluripotent stem cell lines for stem cell researchers at UW–Madison. It operates in conjunction with the iPS (induced pluripotent stem cell) Core at the Waisman Center, and together, both campus resources are called the UW–Madison iPSC Reprogramming and Human Stem Cell Gene Editing Service (iPSC).